Supernus Pharmaceuticals, Inc.SUPNNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-3.27%
↓ 178% below average
Average (39q)
4.18%
Historical baseline
Range
High:31.74%
Low:-26.81%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -3.27% |
| Q2 2025 | 10.86% |
| Q1 2025 | -9.46% |
| Q4 2024 | -6.35% |
| Q3 2024 | 5.12% |
| Q2 2024 | 18.12% |
| Q1 2024 | -11.99% |
| Q4 2023 | 7.75% |
| Q3 2023 | 17.30% |
| Q2 2023 | -12.15% |
| Q1 2023 | -9.75% |
| Q4 2022 | -4.69% |
| Q3 2022 | 1.26% |
| Q2 2022 | 11.16% |
| Q1 2022 | -5.27% |
| Q4 2021 | 8.96% |
| Q3 2021 | 12.10% |
| Q2 2021 | 0.28% |
| Q1 2021 | -7.24% |
| Q4 2020 | -6.52% |
| Q3 2020 | 13.02% |
| Q2 2020 | 30.30% |
| Q1 2020 | -5.72% |
| Q4 2019 | -1.02% |
| Q3 2019 | -3.31% |
| Q2 2019 | 23.06% |
| Q1 2019 | -26.81% |
| Q4 2018 | 13.12% |
| Q3 2018 | 3.06% |
| Q2 2018 | 9.99% |
| Q1 2018 | 3.41% |
| Q4 2017 | 10.68% |
| Q3 2017 | 5.81% |
| Q2 2017 | 31.74% |
| Q1 2017 | -6.78% |
| Q4 2016 | 9.78% |
| Q3 2016 | 11.98% |
| Q2 2016 | 16.15% |
| Q1 2016 | 2.96% |
| Q4 2015 | 9.70% |